Prader-Willi Syndrome (PWS) through the eyes of a physician, an allied health professional, and a caregiver
Learn more about PWS diagnosis and features in neonates, children, adolescents and adults; the importance of ongoing care; and the key aspects of daily life and support for people living with PWS and their families.
Acromegaly Through the Eyes of a Physician, a Nurse, and a Patient | Detection, Diagnosis, Treatment, and Follow-up Care
Explore the challenges faced by physicians, nurses, and patients in terms of detection, diagnosis, treatment, and follow-up care in acromegaly.
Are you familiar with the known and unknown safety risks in long-term GH therapy? During this session, Peter Clayton (UK) and Charlotte Höybye (Sweden) discuss how to improve long-term safety of pediatric and adult GH replacement.
Transitioning hypopituitary patients from childhood to adulthood: what do endocrinologists need to know?
During the session, the experts discuss the diagnostic challenges including the need for endocrine retesting, define criteria for continued care vs. discontinuation, and review the therapeutic shifts during the transition phase.
This session will provide an overview of the diagnosis and therapy of patients with GHD in adulthood focusing on diagnostic tests, hormone interactions, and the monitoring of efficacy and safety.
This session will help you recognize the different etiologies of the polyuria polydipsia syndrome, identify the limitations of the water deprivation test, interpret copeptin upon hypertonic saline infusion, understand non-osmotic stimuli of copeptin and their possible value in the differential diagnosis of Diabetes insipidus, have a better understanding of the pathophysiology of post-operative and post-traumatic diabetes insipidus, including the triphasic response and adipsic diabetes insipidu...
Join this session to become familiar with the rapidly changing field of GH treatment, particularly with regard to the move to promoting patient adherence and improving quality of life through the use of long-acting GH molecules.
During this interactive debate organized in partnership with the World Alliance of Pituitary Organizations (WAPO), the experts talk about the common symptoms of Adult GHD, the lack of consensus on the preferred diagnostic model, the common controversies around starting dosages, novel pharmacological therapies, the benefits and risks of continuing therapy, and important psychological and social well-being factors faced by adult GHD patients.